Hypofractionated Radiotherapy with Cyberknife for Localised Prostate Cancer: Early Experience

被引：0

作者：

Tree, A. ^{[1
]}

Wells, E. ^{[1
]}

Khoo, V. ^{[1
]}

van As, N. ^{[1
]}

机构：

[1] Royal Marsden NHS Fdn Trust, London, England

来源：

CLINICAL ONCOLOGY | 2013年 / 25卷 / 04期

关键词：

STEREOTACTIC BODY RADIOTHERAPY;

D O I：

10.1016/j.clon.2012.12.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E72 / E73

页数：2

共 50 条

[11] Proton Versus CyberKnife Therapy Planning for Hypofractionated Treatment of Prostate With Focal Boost [J].

Yeo, Inhwan ;

Goughenour, Alexander ;

Cernica, George ;

Nie, Wei ;

Joo, Mindy ;

Wang, Peng ;

Fan, Jiajin ;

Parniani, Ashkan ;

Kanani, Samir .

INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2024, 14

[12] Prostate-specific antigen kinetics after hypofractionated stereotactic body radiotherapy for localized prostate cancer [J].

Kim, H. J. ;

Phak, J. H. ;

Kim, W. Ch. .

INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2016, 14 (04) :297-303

[13] The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience [J].

Dincer, Selvi ;

Uysal, Emre ;

Berber, Tanju ;

Akboru, Mustafa Halil .

AGING MALE, 2021, 24 (01) :50-57

[14] Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer [J].

Ung, M. ;

Bossi, A. ;

Abbassi, L. ;

Vautier, J. ;

Anthonipillai, V ;

Cheve, M. ;

Blanchard, P. .

CANCER RADIOTHERAPIE, 2021, 25 (03) :237-241

[15] Ultrahypofractionated radiotherapy for localised prostate cancer: The impact of daily MRI-guided adaptive radiotherapy on delivered dose [J].

Alexander, S. E. ;

Mitchell, R. A. ;

Dunlop, A. ;

Herbert, T. ;

Morrison, K. ;

Nartey, J. ;

Oelfke, U. ;

McNair, H. A. ;

Tree, A. C. .

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 53

[16] Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancer, Cyberknife-M6 Experience [J].

Sarihan, S. ;

Tunc, S. G. ;

Irem, Z. K. ;

Kahraman, A. .

JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S213-S214

[17] Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer [J].

Greco, Carlo ;

Pares, Oriol ;

Pimentel, Nuno ;

Louro, Vasco ;

Nunes, Beatriz ;

Kociolek, Justyna ;

Marques, Joao ;

Fuks, Zvi .

RADIOTHERAPY AND ONCOLOGY, 2022, 169 :35-42

[18] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer [J].

Mekhail Anwar ;

Vivian Weinberg ;

Zachary Seymour ;

I. Joe Hsu ;

Mack Roach ;

Alex R. Gottschalk .

Radiation Oncology, 11

[19] Hypofractionated Radiotherapy in Localized, Low-Intermediate-Risk Prostate Cancer: Current and Future Prospectives [J].

Lo Greco, Maria Chiara ;

Marletta, Giulia ;

Marano, Giorgia ;

Fazio, Alessandro ;

Buffettino, Emanuele ;

Iudica, Arianna ;

Liardo, Rocco Luca Emanuele ;

Milazzotto, Roberto ;

Foti, Pietro Valerio ;

Palmucci, Stefano ;

Basile, Antonio ;

Marletta, Francesco ;

Cuccia, Francesco ;

Ferrera, Giuseppe ;

Parisi, Silvana ;

Pontoriero, Antonio ;

Pergolizzi, Stefano ;

Spatola, Corrado .

MEDICINA-LITHUANIA, 2023, 59 (06)

[20] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer [J].

Anwar, Mekhail ;

Weinberg, Vivian V. ;

Seymour, Zachary ;

Hsu, I. Joe ;

Roach, Mack, III ;

Gottschalk, Alex R. .

RADIATION ONCOLOGY, 2016, 11

← 1 2 3 4 5 →